Evidence map›Paper›PMID 42353100›Full record

ArticleInternational journal of molecular sciences2026

Immunodominant IgM Epitopes of the

Paloma Napoleão-Pêgo, Guilherme C Lechuga, João P R S Carvalho, Flávio R da Silva, Karyne Rangel, Mariana S Freita, Jessica A Waterman, Arnaldo Mandonado-Junior, Carlos Graeff-Teixeira, Salvatore G De-Simone

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paloma Napoleão-PêgoCenter for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 22040-036, RJ, Brazil.
Guilherme C LechugaCenter for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 22040-036, RJ, Brazil.ORCID 0000-0003-4538-3802
João P R S CarvalhoCenter for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 22040-036, RJ, Brazil.
Flávio R da SilvaCenter for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 22040-036, RJ, Brazil.ORCID 0000-0002-7819-7654
Karyne RangelCenter for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 22040-036, RJ, Brazil.
Mariana S FreitaCenter for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 22040-036, RJ, Brazil.
Jessica A WatermanCenter for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 22040-036, RJ, Brazil.
Arnaldo Mandonado-JuniorLaboratory of Biology and Parasitology of Wild Mammals Reservoirs, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, RJ, Brazil.
Carlos Graeff-TeixeiraInfectious Diseases Unit, Department of Pathology, Federal University of Espirito Santo, Vitória 29075-910, ES, Brazil.
Salvatore G De-SimoneCenter for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 22040-036, RJ, Brazil.ORCID 0000-0002-2172-656X

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro 010.101.029/2018
6 · The paper itself

Abstract

Angiostrongyliasis, the primary cause of eosinophilic meningitis, represents an emerging disease caused by

Indexed as

Angiostrongylus cantonensisGalectin 1Galectin 2Immunodominant EpitopesImmunoglobulin MStrongylida InfectionsAmino Acid SequenceAnimalsAntibodies, HelminthAntigens, HelminthEnzyme-Linked Immunosorbent AssayEpitope MappingHelminth ProteinsHumansAntibodies, HelminthAntigens, HelminthGalectin 1Galectin 2Helminth ProteinsImmunodominant EpitopesImmunoglobulin MAngiostrongylus cantonensischimeric polypeptidesELISAgalectin-1galectin-2IgM epitopesimmunological diagnosis

Identifiers

PMID42353100
PMCPMC13299376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.